{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:03:32Z","timestamp":1761919412075},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Science Fund for Distinguished Young Scholars of China","award":["30525018"],"award-info":[{"award-number":["30525018"]}]},{"DOI":"10.13039\/501100012166","name":"National Basic Research Program of China","doi-asserted-by":"crossref","award":["2007CB512003"],"award-info":[{"award-number":["2007CB512003"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"name":"China Doctoral Foundation","award":["20060246079"],"award-info":[{"award-number":["20060246079"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["30930043"],"award-info":[{"award-number":["30930043"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.bbrc.2010.11.037","type":"journal-article","created":{"date-parts":[[2010,11,20]],"date-time":"2010-11-20T09:24:02Z","timestamp":1290245042000},"page":"28-33","source":"Crossref","is-referenced-by-count":23,"title":["High density lipoprotein downregulates angiotensin II type 1 receptor and inhibits angiotensin II-induced cardiac hypertrophy"],"prefix":"10.1016","volume":"404","author":[{"given":"Li","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingyi","family":"Ge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoliang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junbo","family":"Ge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunzeng","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2010.11.037_b0005","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJM199012133232413","article-title":"Prognostic implications of echocardiographically determined left-ventricular mass in the framingham heart-study \u2013 reply","volume":"323","author":"Levy","year":"1990","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.bbrc.2010.11.037_b0010","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/cvr\/cvp285","article-title":"Role of nuclear unphosphorylated STAT3 in angiotensin II type 1 receptor-induced cardiac hypertrophy","volume":"85","author":"Yue","year":"2010","journal-title":"Cardiovascular Research"},{"key":"10.1016\/j.bbrc.2010.11.037_b0015","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1093\/cvr\/cvn230","article-title":"Angiotensin II type-1 receptor activation in the adult heart causes blood pressure-independent hypertrophy and cardiac dysfunction","volume":"81","author":"Ainscough","year":"2009","journal-title":"Cardiovascular Research"},{"key":"10.1016\/j.bbrc.2010.11.037_b0020","first-page":"1223","article-title":"Mice with cardiomyocyte-restricted smad4 deletion resist to angiotensin II induced cardiac hypertrophy","volume":"116","author":"Oin","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.bbrc.2010.11.037_b0025","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S1567-4215(07)60123-4","article-title":"Calsarcin-1 inhibits angiotensin-II induced cardiac hypertrophy in vivo and in vitro","volume":"6","author":"Frank","year":"2007","journal-title":"European Journal of Heart Failure"},{"key":"10.1016\/j.bbrc.2010.11.037_b0030","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1161\/01.CIR.0000135475.35758.23","article-title":"Heme oxygenase-1 inhibits angiotensin II-induced cardiac hypertrophy in vitro and in vivo","volume":"110","author":"Hu","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.bbrc.2010.11.037_b0035","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1046\/j.1440-1681.2003.03831.x","article-title":"Endothelin ETA receptor antagonism does not attenuate angiotensin II-induced cardiac hypertrophy in vivo in rats","volume":"30","author":"De Smet","year":"2003","journal-title":"Clinical and Experimental Pharmacology and Physiology"},{"key":"10.1016\/j.bbrc.2010.11.037_b0040","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1161\/01.CIR.0000164237.58200.5A","article-title":"Requirement of nuclear factor-kappa B in angiotensin II- and isoproterenol-induced cardiac hypertrophy in vivo","volume":"111","author":"Freund","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.bbrc.2010.11.037_b0045","first-page":"43","article-title":"Overexpression of angiotensin II type 1 receptor in cardiomyocytes induces cardiac hypertrophy and remodeling","volume":"100","author":"Paradis","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.bbrc.2010.11.037_b0050","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0022-2275(20)39898-9","article-title":"Molecular physiology of reverse cholesterol transport","volume":"36","author":"Fielding","year":"1995","journal-title":"Journal of Lipid Research"},{"key":"10.1016\/j.bbrc.2010.11.037_b0055","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1172\/JCI114722","article-title":"Plasma high-density lipoproteins \u2013 metabolism and relationship to atherogenesis","volume":"86","author":"Tall","year":"1990","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.bbrc.2010.11.037_b0060","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1016\/S0140-6736(05)74306-3","article-title":"Endotoxin-lipoprotein hypothesis","volume":"356","author":"Clunn","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.bbrc.2010.11.037_b0065","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1016\/j.jacc.2005.06.080","article-title":"High-density lipoprotein function \u2013 recent advances","volume":"46","author":"Ansell","year":"2005","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.bbrc.2010.11.037_b0070","doi-asserted-by":"crossref","first-page":"865","DOI":"10.3109\/00365510903359237","article-title":"High-density lipoprotein is superior to B-type natriuretic peptide as a marker of systolic dysfunction in an elderly general population","volume":"69","author":"Kerola","year":"2009","journal-title":"Scandinavian Journal of Clinical & Laboratory Investigation"},{"key":"10.1016\/j.bbrc.2010.11.037_b0075","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/sj.jhh.1002203","article-title":"Clusters of metabolic risk factors predict cardiovascular events in hypertension with target-organ damage: the life study","volume":"21","author":"de Simone","year":"2007","journal-title":"Journal of Human Hypertension"},{"key":"10.1016\/j.bbrc.2010.11.037_b0080","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1291\/hypres.30.125","article-title":"High-density lipoprotein cholesterol and insulin resistance are independent and additive markers of left ventricular hypertrophy in essential hypertension","volume":"30","author":"Anan","year":"2007","journal-title":"Hypertension Research"},{"key":"10.1016\/j.bbrc.2010.11.037_b0085","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1177\/089686080802800611","article-title":"High-density lipoprotein cholesterol and left ventricular mass index in peritoneal dialysis","volume":"28","author":"Ikee","year":"2008","journal-title":"Peritoneal Dialysis International"},{"key":"10.1016\/j.bbrc.2010.11.037_b0090","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1161\/01.CIR.102.16.1970","article-title":"Oxidized LDL upregulates angiotensin II type 1 receptor expression in cultured human coronary artery endothelial cells \u2013 the potential role of transcription factor NF-kappa B","volume":"102","author":"Li","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.bbrc.2010.11.037_b0095","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1001\/archinte.163.11.1296","article-title":"Interactions between the renin\u2013angiotensin system and dyslipidemia \u2013 relevance in the therapy of hypertension and coronary heart disease","volume":"163","author":"Singh","year":"2003","journal-title":"Archives of Internal Medicine"},{"key":"10.1016\/j.bbrc.2010.11.037_b0100","first-page":"285","article-title":"Regulation of the angiotensin AT1 receptor expression by hypercholesterolemia","volume":"2","author":"Nickenig","year":"1997","journal-title":"European Journal of Medical Research"},{"key":"10.1016\/j.bbrc.2010.11.037_b0105","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1161\/HYPERTENSIONAHA.108.118919","article-title":"Vascular-protective effects of high-density lipoprotein include the downregulation of the angiotensin II type 1 receptor","volume":"53","author":"Van Linthout","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.bbrc.2010.11.037_b0110","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/nature05602","article-title":"p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload","volume":"446","author":"Sano","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2010.11.037_b0115","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1161\/01.RES.0000038488.38975.1A","article-title":"Involvement of extracellular signal-regulated kinases 1\/2 in cardiac hypertrophy and cell death","volume":"91","author":"Bueno","year":"2002","journal-title":"Circulation Research"},{"key":"10.1016\/j.bbrc.2010.11.037_b0120","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1161\/01.RES.73.3.413","article-title":"Molecular characterization of angiotensin-II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts \u2013 critical role of the At(1) receptor subtype","volume":"73","author":"Sadoshima","year":"1993","journal-title":"Circulation Research"},{"key":"10.1016\/j.bbrc.2010.11.037_b0125","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1056\/NEJM199908053410604","article-title":"Affairs high-density lipoprotein, gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol","volume":"341","author":"Rubins","year":"1999","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.bbrc.2010.11.037_b0130","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1161\/01.ATV.0000142808.34602.25","article-title":"High-density lipoproteins retard the progression of atherosclerosis and favorably remodel lesions without suppressing indices of inflammation or oxidation","volume":"24","author":"Choudhury","year":"2004","journal-title":"Arteriosclerosis Thrombosis and Vascular Biology"},{"key":"10.1016\/j.bbrc.2010.11.037_b0135","first-page":"1433","article-title":"High density lipoproteins and atherosclerosis","volume":"61","author":"Idzior-Walus","year":"2004","journal-title":"Przeglad Lekarski"},{"key":"10.1016\/j.bbrc.2010.11.037_b0140","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.bbalip.2006.06.013","article-title":"Sex differences in atherosclerosis in mice with elevated phospholipid transfer protein activity are related to decreased plasma high density lipoproteins and not to increased production of triglycerides","volume":"1761","author":"Lie","year":"2006","journal-title":"Biochimica Et Biophysica Acta-Molecular and Cell Biology of Lipids"},{"key":"10.1016\/j.bbrc.2010.11.037_b0145","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1124\/jpet.107.129411","article-title":"Anti-inflammatory and cardioprotective activities of synthetic high-density lipoprotein containing apolipoprotein A-I mimetic peptides","volume":"324","author":"Gomaraschi","year":"2008","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.bbrc.2010.11.037_b0150","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s10741-007-9038-x","article-title":"HDL and its sphingosine-1-phosphate content in cardioprotection","volume":"12","author":"Keul","year":"2007","journal-title":"Heart Failure Reviews"},{"key":"10.1016\/j.bbrc.2010.11.037_b0155","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1161\/CIRCULATIONAHA.105.607135","article-title":"High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia\/reperfusion injury in vivo via the S1P(3) lysophospholipid receptor","volume":"114","author":"Theilmeier","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.bbrc.2010.11.037_b0160","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S1567-4215(07)60421-4","article-title":"Inhibitor of angiotensin II type I receptors eprosartan and antiodarone as a combined treatment of advanced heart failure and atrial fibrillation","volume":"6","author":"Grigoryan","year":"2007","journal-title":"European Journal of Heart Failure"},{"key":"10.1016\/j.bbrc.2010.11.037_b0165","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1253\/circj.71.1958","article-title":"Angiotensin II type 1a receptor signals are involved in the progression of heart failure in MLP-deficient mice","volume":"71","author":"Yamamoto","year":"2007","journal-title":"Circulation Journal"},{"key":"10.1016\/j.bbrc.2010.11.037_b0170","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.regpep.2004.04.004","article-title":"Evidence of a novel intracrine mechanism in angiotensin II-induced cardiac hypertrophy","volume":"120","author":"Baker","year":"2004","journal-title":"Regulatory Peptides"},{"key":"10.1016\/j.bbrc.2010.11.037_b0175","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0167-5273(02)00233-4","article-title":"The syndrome of cardiac cachexia","volume":"85","author":"Anker","year":"2002","journal-title":"International Journal of Cardiology"},{"key":"10.1016\/j.bbrc.2010.11.037_b0180","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1161\/CIRCULATIONAHA.109.830984","article-title":"Relations of lipid concentrations to heart failure incidence the framingham heart study","volume":"120","author":"Velagaleti","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.bbrc.2010.11.037_b0185","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1161\/ATVBAHA.107.161042","article-title":"HDL-associated lysosphingolipids inhibit NAD(P)H oxidase-dependent monocyte chemoattractant protein-1 production","volume":"28","author":"Tolle","year":"2008","journal-title":"Arteriosclerosis Thrombosis and Vascular Biology"},{"key":"10.1016\/j.bbrc.2010.11.037_b0190","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1161\/01.HYP.0000237975.90870.eb","article-title":"Angiotensin II signal transduction through small GTP-binding proteins \u2013 mechanism and significance in vascular smooth muscle cells","volume":"48","author":"Ohtsu","year":"2006","journal-title":"Hypertension"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X10020954?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X10020954?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,13]],"date-time":"2021-11-13T21:33:00Z","timestamp":1636839180000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X10020954"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S0006291X10020954"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2010.11.037","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}